Glibclay 2.5 Tablet contains Glibenclamide 2.5mg, a trusted sulfonylurea oral antidiabetic agent widely used to manage blood glucose levels in patients with type 2 diabetes mellitus. It enhances insulin secretion from pancreatic beta cells, helping maintain effective glycemic control.
The 2.5mg strength is commonly prescribed for patients requiring moderate glucose-lowering support or dose escalation as part of personalized diabetes treatment plans. Its predictable action and long clinical history make it a reliable option in routine diabetic care.
Glibenclamide tablets are extensively prescribed by general physicians, diabetologists, and internal medicine specialists. Regular use in OPD and long-term therapy ensures steady demand across retail pharmacies, clinics, and hospital settings.
Adding Glibclay 2.5 Tablet to your diabetes and metabolic-care segment strengthens your portfolio and opens opportunities in pharmacy distribution, hospital procurement, institutional supply, export markets, and third-party manufacturing. Its consistent prescription value makes it a commercially strong and stable antidiabetic product.